When Dr. Oussama Wazni takes over leadership of Cleveland Clinic’s EP section in September, he’ll be doubling down on linking research with practice to take on clinical challenges.
Too many patients diagnosed with cryptogenic stroke haven’t had complete workups. Prolonged rhythm monitoring can help fill the gap, but there’s a role for more thorough initial evaluation too.
The year just passed was full of insights and innovations likely to be felt for many years to come. Here are 15 such developments in which Cleveland Clinic staff played key roles.
The new Centers for Medicare & Medicaid Services proposal restricting reimbursement for the WATCHMAN device may help prevent abuse, but it’s too limiting. Cleveland Clinic experts share their take.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
The left atrial appendage (LAA) is a perennial target for preventing stroke in afib patients. Now that the long-awaited WATCHMAN device for LAA closure is available, a team of experts assess its role.
Co-Directors of Cleveland Clinic’s High-risk Anticoagulation Clinic explain medication and procedural options for patients with atrial fibrillation who have a history of internal bleeding.
Catheter ablation bested amiodarone for atrial fibrillation control in heart failure patients in a recent study. Here’s why a Cleveland Clinic electrophysiologist says it’s likely worth the risks in these patients.